Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.260
+0.050 (4.13%)
At close: Jul 2, 2026, 4:00 PM EDT
1.240
-0.020 (-1.59%)
After-hours: Jul 2, 2026, 7:06 PM EDT
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $47.44 million as of July 2, 2026. Its market cap has decreased by -13.09% in one year.
Market Cap
47.44M
Enterprise Value
-53.54M
1-Year Change
-13.09%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $47.44M, a decrease of -91.57%. That is a compound annual growth rate of -64.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 47.44M | -22.01% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Impact BioMedical | 50.89M |
| Eloxx Pharmaceuticals | 50.72M |
| Lantern Pharma | 50.65M |
| Dogwood Therapeutics | 50.11M |
| Radiopharm Theranostics | 49.16M |
| Veru Inc. | 49.11M |
| CervoMed | 48.02M |
| PDS Biotechnology | 47.62M |